SHERINE SOLOMON: Open Payments
NPI 1336523406 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 34 payments from 12 companies in 2025. Trend: 2023 $890 · 2024 $835 · 2025 $1,791
Food & beverage: $1,791
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $505 |
| Novo Nordisk Inc | 11 | $335 |
| Amgen Inc. | 5 | $298 |
| Sequel Med Tech, LLC | 4 | $194 |
| Tandem Diabetes Care, Inc. | 1 | $152 |
| Medtronic, Inc. | 2 | $146 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| CeQur Corporation | 1 | $25 |
Products named: FREESTYLE LIBRE 3, Ozempic, TEPEZZA, TWIIST, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, GVOKE HYPOPEN, TZIELD.
Industry payments across CT — which companies pay providers there.
